E V Leinonen
Overview
Explore the profile of E V Leinonen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anttila A, Rasanen L, Leinonen E
Ann Pharmacother
. 2001 Oct;
35(10):1221-3.
PMID: 11675851
Objective: To report two cases of interaction between fluvoxamine and mirtazapine. Case Summary: A 17-year-old boy was treated with mirtazapine 30 mg/d. The addition of fluvoxamine 100 mg/d to the...
2.
Anttila S, Leinonen E
CNS Drug Rev
. 2001 Oct;
7(3):249-64.
PMID: 11607047
The novel antidepressant mirtazapine has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well...
3.
Seppala N, Leinonen E, Lehtonen M, Kivisto K
Pharmacol Toxicol
. 1999 Dec;
85(5):244-6.
PMID: 10608488
Serum concentrations of clozapine and its main metabolite demethylclozapine were measured in 44 schizophrenic inpatients, of whom ten were non-smokers and 34 smokers. When comparing their clozapine dose and body...
4.
Lepola U, Wade A, Leinonen E, Koponen H, Frazer J, Sjodin I, et al.
J Clin Psychiatry
. 1998 Nov;
59(10):528-34.
PMID: 9818634
Background: The objective of this study was to evaluate the efficacy and tolerability of citalopram in the long-term treatment of adult outpatients with panic disorder with or without agoraphobia. Method:...
5.
Koponen H, Lepola U, Leinonen E
Eur Neuropsychopharmacol
. 1993 Dec;
3(4):517-9.
PMID: 8111225
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication of neuroleptic treatment. The authors describe a case of NMS during treatment with a new atypical neuroleptic, remoxipride. To their knowledge,...